Alcohol Screening and Preoperative Intervention Research Study - 2
Launched by UNIVERSITY OF MICHIGAN · Mar 13, 2023
Trial Information
Current as of August 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Alcohol Screening and Preoperative Intervention Research Study - 2 is looking at ways to help people reduce their alcohol consumption before and after surgery. The goal is to see if these treatments can improve surgical outcomes and promote better long-term health. This study is currently recruiting participants who are scheduled for certain major surgeries in the next 5 to 12 weeks and have indicated they may have a problem with drinking. To qualify, individuals must be 18 years or older, be willing to participate fully in the study, and have access to a smartphone or computer with internet.
Participants can expect to take part in various treatment programs designed to help reduce their alcohol use. They will need to complete a consent form, a survey about their alcohol use, and a phone call for enrollment. It's important to note that those who are currently enrolled in another alcohol study, have a history of severe alcohol withdrawal, or cannot understand English will not be eligible. This study aims to provide support for those who may be at risk for complications during surgery due to their drinking habits, ultimately leading to healthier surgical experiences.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Completed consent form, baseline survey, and enrollment phone call
- • 2. Willingness to comply with all study procedures and availability for the duration of the study
- • 3. Scheduled for select major elective surgery (non-cancer) in the next 5-12 weeks
- • 4. Score ≥ 5 on the Alcohol Use Disorders Identification Test-Concise (AUDIT-C) based on research linking this score with increased risk of surgical complications
- • 5. Access to a smart device or computer access with internet or wi-fi connection throughout the study period
- Exclusion Criteria:
- • 1. Exclude participants enrolled in another research study focused on alcohol use
- • 2. History of severe alcohol withdrawal
- • 3. Unable to speak, understand, or read English
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Anne Fernandez
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials